{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "PAYC",
  "name": "Paycom Software, Inc.",
  "url": "https://orbyd.app/dossiers/PAYC/",
  "json_url": "https://orbyd.app/dossiers/PAYC.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": null,
  "archetype": {
    "code": "a4",
    "n": 4
  },
  "current_thesis": "Automation-and-buyback operating-leverage story re-rating a de-rated HCM name: Q2 (2026-08-05) beat revenue $531.2M vs $513.1M and EPS $2.78 vs $2.38, FY26 guide lifted to $2.197–2.212B, nine targets raised 2026-08-06. Leg is fresh, but $214.94 already sits above the $210 median of those raised targets with no catalyst until the ~November Q3 print.",
  "invalidation_trigger": "A weekly close below $195 (surrenders the post-Q2 advance and puts price under every one of the nine targets raised 2026-08-06/07); secondarily, a Q3 print (~2026-11-04, est.) that trims the 8–9% FY26 recurring-revenue guide or shows adjusted EBITDA margin at or below Q2's 44.2%.",
  "catalyst_date": null,
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "ai-enterprise-software"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Chad Richison holds ~20% of shares outstanding; founder voting concentration is a standing governance feature of this name.",
    "Interest earned on funds held for clients is a rate-sensitive revenue line; front-end rate moves affect revenue independent of unit growth.",
    "Q1 carries seasonal year-end tax-form filing revenue, so sequential quarter-over-quarter revenue comparisons are not clean.",
    "Quarterly dividend of $0.375/share is declared by the board each quarter and is not a fixed commitment.",
    "Reported under Software/Technology by most classifications but appears in some vendors' Industrials mover screens; screen-based comps can be misleading."
  ],
  "body_markdown": "## Current Thesis\n\nThe leg being bought is operating leverage, not growth reacceleration. Paycom's Q2 2026 print (released after the close on 2026-08-05) delivered revenue of $531.2M against a $513.101M consensus and non-GAAP diluted EPS of $2.78 against $2.38, and management raised the FY26 revenue range to $2.197–2.212B from $2.175–2.195B. Nine sell-side targets were lifted on 2026-08-06 and 2026-08-07. What the market is paying for is the combination of ~46% full-year adjusted EBITDA margin at the company's own guided midpoint, mid-single-digit-to-high-single-digit recurring revenue growth, and a share count being actively shrunk — The complication is entry: the stock closed 2026-08-07 at $214.94 with RSI(14) at 81.0 after a 57.5% three-month advance, and the median of those nine freshly raised targets is $210.\n\n## Bull Case\n\n- **Q2 2026 beat on both lines (2026-08-05):** total revenue $531.2M, +9.8% YoY from $483.6M, versus $513.101M consensus. Recurring and other revenue $505.2M, +11.0% YoY, 95.1% of total — the annuity base grew faster than the reported top line.\n- **Profitability ahead of the model:** adjusted EBITDA $235.0M at a 44.2% margin; GAAP net income $107.4M ($2.34 per diluted share); non-GAAP diluted EPS $2.78 versus a $2.38 estimate.\n- **Guide raised, not just met:** the new FY26 low end ($2.197B) sits above the old high end ($2.195B). FY26 adjusted EBITDA guided to $1.007–1.022B, which the company frames as roughly a 46% margin at the midpoint — above the 44.2% just printed, so H2 carries the expansion.\n- A quarterly dividend of $0.375 was declared 2026-08-03, record 2026-08-24, payable 2026-09-08.\n- **Coverage repriced in one session:** on 2026-08-06, KeyBanc went to $270 (Overweight), TD Cowen $244 (Buy), BTIG $230 (Buy), Guggenheim $225 (Buy), Barclays $210 (Equal-Weight), UBS $205 (Buy), Stifel $200 (Hold), Cantor $195 (Neutral); Citigroup followed on 2026-08-07 at $194 (Neutral).\n- **No insider distribution surfaced into the move:** the most recent CEO Form 4 activity found is a 25,000-share bona fide gift dated 2026-06-15, after which Chad Richison held 2,774,921 shares directly. No equity issuance accompanied the run.\n\n## Bear Case\n\n- **The guide embeds H2 deceleration.** Q2 total revenue grew 9.8% and recurring grew 11.0%; the company frames FY26 as approximately 7–8% total growth and 8–9% recurring growth. Arithmetic on the company's own framing points to slower second-half growth than the quarter just delivered.\n- **The raise is small next to the beat.** Q2 revenue exceeded consensus by a visible margin, yet the full-year low end moved only just past the prior high end. That pattern is consistent with flowing the quarter through rather than upgrading H2 assumptions.\n- **Price is through most of the new targets.** Five of the nine targets raised on 2026-08-06/07 — Citi $194, Cantor $195, Stifel $200, UBS $205, Barclays $210 — sit at or below the 2026-08-07 close of $214.94. Median of the nine is $210.\n- **Ratings did not follow the numbers.** Citigroup (Neutral), Cantor (Neutral), Stifel (Hold) and Barclays (Equal-Weight) all maintained their stance while raising the target — the target moves are mark-to-market, not upgrades.\n- **Margin help may be partly discretionary.** A third-party summary of the quarter (Pulse2, 2026-08-05) attributed the profit outperformance to recurring growth, margin expansion, *lower research spending*, and a reduced share count. Cost restraint compounds differently than product-driven leverage.\n- **Buyback funding is tighter.** Cash and equivalents fell to $198.0M from $370.0M at 2025 year-end after the Q2 repurchase. Sustaining a $345.9M-per-quarter pace from balance-sheet cash is a different proposition at $198.0M.\n- **Extension.** RSI(14) 81.0 and +57.5% over three months as of 2026-08-07, with the next scheduled company event roughly 90 days out.\n\n## Setup & Price Structure\n\nLast completed daily close $214.94 (2026-08-07), 7.2% below the 52-week high of $231.71, three-month return +57.5%, RSI(14) 81.0. The name gapped higher on 2026-08-06 — Benzinga reported shares indicated +14.1% pre-market — and has held the bulk of that gap through the following session.\n\n**Life-cycle: ACCELERATING.** What dates it: the attention arrived on 2026-08-06, when nine brokers moved targets in a single session off the 2026-08-05 print, and the stock's move that day put it into multiple intraday-mover screens. New estimates, new headlines, expanding participation. That is an early-leg signature, but the crowding evidence is the kind that shows up in the back half of one: an RSI in the low 80s, a majority of the freshly raised targets below spot, and a first resistance shelf at the 52-week high $231.71 that has not been tested since the print.\n\nObservables on positioning, stated without a verdict: no secondary or convertible issuance accompanied the advance; the company was the buyer of size in the quarter ($345.9M); insider activity in the last 60 days that surfaced is a gift, not an open-market sale; the next earnings date does not fall inside 30 days, so there is no imminent binary compressing the setup.\n\n## Catalyst Calendar (next 30 days)\n\n- **2026-08-24** — record date for the $0.375/share quarterly dividend declared 2026-08-03. Mechanical; resolves nothing about the growth or margin thesis.\n- **2026-09-08** — dividend payment date (just past the 30-day window).\n- **~2026-11-04 (est.)** — Q3 2026 results. Paycom has historically reported Q3 in the first week of November; the date is not yet confirmed. This is the first event that tests whether the 8–9% FY26 recurring guide is a floor and whether H2 adjusted EBITDA margin clears the 44.2% printed in Q2.\n\nThere is no company-scheduled event inside 30 days that resolves the thesis. That vacuum is itself the structural feature of the setup: the narrative has to be carried by flow and estimate revision for roughly three months before the next hard datapoint.\n\n## What Would Change Our Mind\n\nThe thesis stands on two numbers holding. First, recurring revenue growth of 8–9% has to behave as a floor rather than a ceiling; a Q3 print (~2026-11-04, est.) that trims that range removes the growth backstop under the margin story and leaves the buyback carrying EPS alone. Second, FY26 adjusted EBITDA margin has to expand toward the guided ~46% midpoint — a Q3 adjusted EBITDA margin at or below the 44.2% delivered in Q2 would contradict the operating-leverage claim the re-rating is priced on.\n\nOn structure: a weekly close below $195 would put price back under every one of the nine targets raised on 2026-08-06/07 and surrender the post-print advance, which would read as the market rejecting the guidance raise rather than digesting it. A cash balance that falls materially below the $198.0M reported at quarter-end without a corresponding debt facility would also mark the repurchase pace as unsustainable at Q2's level.\n\nIf the theme flips to SATURATED — a second wave of coverage arriving with no accompanying estimate revision — the accelerating label above stops applying and the crowding observables become the dominant read.\n\n## Correlation Notes\n\n- **Mid-market HCM cohort.** Trades with Paylocity (PCTY) and, less tightly, ADP and Paychex (PAYX). A guidance disappointment from a direct comp on mid-market unit growth reads across directly, since all four sell per-employee-per-month.\n- **US mid-market employment.** Revenue scales with employees on customer payrolls, so monthly nonfarm payrolls and small/mid-business headcount data feed the recurring line with a lag. Headcount contraction at existing clients hits revenue without any logo churn.\n- **Short-term rates.** Interest earned on funds held for clients is a rate-sensitive revenue component for every payroll processor; a cutting cycle compresses it, and a repricing of the front end is a shared factor across the group regardless of unit growth.\n- **Software factor beta.** A high-margin, high-multiple SaaS name moves with the broad software complex on rate-driven multiple swings; on 2026-08-06 the tape itself was mixed (S&P 500 and Dow lower on a 4% Brent move), so the +14.1% indicated gap was idiosyncratic rather than beta.",
  "first_seen": "2026-07-30",
  "last_analyzed": "2026-08-09T08:10:07+00:00",
  "last_synthesized": "2026-08-08",
  "last_update_source": "theme_discovery",
  "license": "Content © orbyd. Cite the canonical URL."
}